Jun 26 |
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
|
Jun 6 |
All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy
|
May 15 |
Cyclacel Pharmaceuticals Inc (CYCC) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
|
May 15 |
Cyclacel Pharmaceuticals, Inc. (CYCC) Q1 2024 Earnings Call Transcript
|
May 14 |
Cyclacel Pharmaceuticals GAAP EPS of -$2.27 beats by $2.48
|
May 14 |
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update
|
May 8 |
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
|
May 6 |
Cyclacel Pharmaceuticals files to sell 15.2M shares for holders
|
May 2 |
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules
|
Apr 30 |
Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
|